finally , we are witnessing the emergence of several chemotherapy agents that promise impressive activity in cll ( e.g. , 2'-deoxycoformycin [ 3 ] , fludarabine monophosphate [ 4 , 5 ] ) , and thereby offer the potential for improving survival time in this disease .
C0023434
cll
C0060483
fludarabine monophosphate